Trial intelligence / Profile preview

Phase II randomized study of oral vinorelbine/capecitabine, sequential oral vinorelbine then capecitabine, versus docetaxel/capecitabine in metastatic breast cancer

2004-005205-30Phase 2Completed

Sponsor
Pierre Fabre Laboratories
Start
Jul 2005
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of vinorelbine, capecitabine, docetaxel in breast cancer, sponsored by Pierre Fabre Laboratories. Started Jul 2005; status: completed.

02

Drugs

vinorelbinecapecitabinedocetaxel
03

Conditions

breast cancer

Beyond the preview

Go deeper on 2004-005205-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-005205-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call